Pancreum integrates an insulin pump, a glucagon pump, and a continuous glucose monitor into a single tubeless wearable — controlled entirely from your smartphone.
The integrated CGM continuously reads glucose levels. The algorithm analyzes the trend and determines the optimal response. The dual pumps deliver precise doses of insulin or glucagon as needed. You monitor and manage everything through the smartphone app.
Automated insulin delivery that responds to real-time glucose data from the integrated CGM.
Precise micro-dosing adjusts continuously throughout the day and night.
Built-in glucagon delivery provides an automatic safety net against dangerous hypoglycemia.
No separate emergency kit needed — the device responds before you even feel the low.
Glucose sensing integrated directly into the wearable. No separate device, transmitter, or adhesive patches.
Real-time readings feed the algorithm that controls both hormone pumps.
The Pancreum smartphone app puts you in control. View real-time glucose data, receive alerts, review dosing history, and share data with your care team — all from the device you already carry.
Complete control from the device you already carry
Today's smartphone-controlled device is the foundation. Our roadmap leads to a fully autonomous AI platform that learns your patterns, predicts your needs, and manages diabetes with zero manual intervention.
Phase 1
Smartphone Control
User-directed dosing with smart suggestions and safety automation
Phase 2
Adaptive Algorithm
AI learns individual patterns and automates routine decisions
Phase 3
Full Autonomy
Fully AI-controlled platform with zero manual intervention required
4 issued patents and 1 pending create a robust intellectual property position protecting the integrated dual-hormone, tubeless wearable design.
US 9,248,235
Utility Patent
US 11,833,328
Utility Patent
US D704,325
Design Patent
Pending
Utility Patent